The Philippines: an attractive OTC and pharma market
The Philippines have a really attractive consumer healthcare and pharma market that you should consider if you are looking to expand your business internationally.
The Philippines can be included among the top ten most attractive OTC and prescription drug markets in the Asia-Pacific region. Unfortunately, their healthcare system is so obsolete that the market is unable to meet the healthcare product quota that a big population demands.
The OTC and pharma market is currently valued at USD 2,1 billion. It is a fast-growing market – expanding faster than the country’s national output. The self-medication and Rx market should reach USD 5,2 Billion ex-factory in 2035.
At present, market access in the Philippines—with the help of a systematically selected local partner—is still a relatively simple and non-cost-intensive option. The OTC and Pharma markets in neighbouring countries, such as Thailand and Malaysia, also show some potential, albeit not on the level of the TRIUMPH markets.
If you are planning on entering the Philippines, our expertise and long-standing network can support you. The Chameleon Pharma Consulting Group has extensive OTC and pharma expertise in South East Asian markets, and we would be thrilled to help you to take advantage of the golden opportunities this region has to offer!
The Philippines OTC and pharma market in 2035
USD 5,2 Billion
OTC and pharma market size, ex-factory
OTC and pharma market growth
The Philippines in numbers
Interested in this market ?
We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.